This story discusses findings of a meta-analysis, or review of many studies, of anti-viral medications conducted by European researchers and published in the Lancet. According to this review of 51 randomized controlled trials, antiviral drugs such as Tamiflu are only effective in reducing symptoms of influenza type A and B by about 50%, and not as effective in the cases of “flu-like” illnesses. Doctors can and should test patients to determine if they have influenza type A and B viruses before prescribing anti-viral medications such as Tamiflu; the drugs should not be taken for flu-like symptoms and non-life threatening influenza. In fact, Tamiflu is ineffective for other types of flu-like illnesses. The main disadvantage of the misuse of anti-viral medications is the risk of developing a resistance to these drugs, which is mentioned in this article. However, there is no mention of side effects of anti-viral drugs, which can include gastrointestinal problems, nausea, insomnia and hallucinations. The risk ofthese side effects is greater in older people. No quantitative data is provided on either side effects or benefits on any of the anti-viral medications. The message perhaps not conveyed strongly enough by this piece is that there is no need to stockpile Tamiflu. Considering that WHO, CDC and other health organizations continue to recommend stockpiling Tamiflu, the cost of this practice would be interesting to note. No information on the cost of anti-viral drugs is provided. There was also little discussion to counter the statement: “Roche and the WHO agreed there aren’t yet large human studies showing that Tamiflu is effective against bird flu. But they said animal studies and anecdotal evidence in humans show the drug is active against the H5N1 avian-flu virus.” There is no credible evidence at this time that Tamiflu is effective against avian flu. Anecdotal evidence and animal studies are insufficient, and further controlled clinical trials on humans are needed to determine if these anti-virals aree effective, safe and appropriate for a large population. Tamiflu reduces the symptoms of the flu by only 1-1.5 days and it may not prevent transmission of the virus. While the drug may be appropriate as flu prevention in a household, it would not likely be very effective during a flu epidemic.
No information on the
cost of anti-viral drugs for treating non A or B strain viruses. No information on global cost for preventative use.
No quantitative estimates of benefits provided in this news story, though they are available in
the journal article upon which the story is based.
No mention of the incidence or severity of side effects of the anti-viral drugs,
which include gastrointestinal problems, nausea, insomnia and hallucinations. More prevalent in older patients.
This was a meta-analysis of 50
clinical trials examining treatment efficacy, prophylactic use and side effects of several anti-viral flu drugs. This needs
to be clearer: it was a study of studies. There was little discussion of the findings to counter the statement: “Roche and
the WHO agreed there aren’t yet large human studies showing that Tamiflu is effective against bird flu. But they said animal
studies and anecdotal evidence in humans show the drug is active against the H5N1 avian-flu virus.” There is no credible
evidence that Tamiflu is effective against avian flu. Anecdotal evidence and animal studies are insufficient and further
controlled clinical trials on humans are needed to determine if these anti-virals are effective, safe and appropriate for a
large population.
Addresses
over-prescription of antiviral drugs in most cases of flu-like symptoms.
Story says the
study was funded by U.K and Italian health depts. in conjunction with Cochrane Collaboration, an independent, non-profit
group.
Mentions disadvantages of
over-prescribing Tamiflu and Relenza when it not indicated, for example, in the case of flu-like symptoms and non-life
threatening influenza. The main disadvantage is developing a resistance to the antiviral drugs.
This product is FDA
approved to treat Type A and B influenza, but no mention of FDA approval in story. This is relevant to the story if talk of
off-label treatment is being evaluated (i.e. other flu strains and avian flu).
Mentions that this treatment
is not as effective as previously thought at reducing symptoms or for controlling transmission of influenza.
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.